349 related articles for article (PubMed ID: 22318421)
1. The kallikrein-kinin system in diabetic nephropathy.
Tomita H; Sanford RB; Smithies O; Kakoki M
Kidney Int; 2012 Apr; 81(8):733-44. PubMed ID: 22318421
[TBL] [Abstract][Full Text] [Related]
2. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice.
Kakoki M; Sullivan KA; Backus C; Hayes JM; Oh SS; Hua K; Gasim AM; Tomita H; Grant R; Nossov SB; Kim HS; Jennette JC; Feldman EL; Smithies O
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10190-5. PubMed ID: 20479236
[TBL] [Abstract][Full Text] [Related]
3. Tibial post fracture pain is reduced in kinin receptors deficient mice and blunted by kinin receptor antagonists.
Minville V; Mouledous L; Jaafar A; Couture R; Brouchet A; Frances B; Tack I; Girolami JP
J Transl Med; 2019 Oct; 17(1):346. PubMed ID: 31640792
[TBL] [Abstract][Full Text] [Related]
4. The kallikrein-kinin system and oxidative stress.
Kayashima Y; Smithies O; Kakoki M
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):92-6. PubMed ID: 22048723
[TBL] [Abstract][Full Text] [Related]
5. The kallikrein-kinin system.
Tang SC; Leung JCK; Lai KN
Contrib Nephrol; 2011; 170():145-155. PubMed ID: 21659767
[TBL] [Abstract][Full Text] [Related]
6. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
7. The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
da Costa PLN; Wynne D; Fifis T; Nguyen L; Perini M; Christophi C
BMC Cancer; 2018 Apr; 18(1):382. PubMed ID: 29618333
[TBL] [Abstract][Full Text] [Related]
8. Plasma Kallikrein-Kinin system mediates immune-mediated renal injury in trichloroethylene-sensitized mice.
Wang H; Zhang JX; Ye LP; Li SL; Wang F; Zha WS; Shen T; Wu C; Zhu QX
J Immunotoxicol; 2016 Jul; 13(4):567-79. PubMed ID: 27027470
[TBL] [Abstract][Full Text] [Related]
9. The role of the renal kallikrein-kinin system in diabetic nephropathy.
Riad A; Zhuo JL; Schultheiss HP; Tschöpe C
Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067
[TBL] [Abstract][Full Text] [Related]
10. The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis.
Lim SK; Park SH
Life Sci; 2012 Nov; 91(19-20):895-906. PubMed ID: 22877648
[TBL] [Abstract][Full Text] [Related]
11. Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
Rodrigues ES; Silva RF; Martin RP; Oliveira SM; Nakaie CR; Sabatini RA; Merino VF; Pesquero JB; Bader M; Shimuta SI
Peptides; 2013 Apr; 42():1-7. PubMed ID: 23306173
[TBL] [Abstract][Full Text] [Related]
12. Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies.
Othman R; Cagnone G; Joyal JS; Vaucher E; Couture R
Cells; 2021 Jul; 10(8):. PubMed ID: 34440682
[TBL] [Abstract][Full Text] [Related]
13. Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes.
Potier L; Waeckel L; Vincent MP; Chollet C; Gobeil F; Marre M; Bruneval P; Richer C; Roussel R; Alhenc-Gelas F; Bouby N
J Pharmacol Exp Ther; 2013 Jul; 346(1):23-30. PubMed ID: 23591995
[TBL] [Abstract][Full Text] [Related]
14. The kallikrein-kinin system in diabetic kidney disease.
Liu W; Stanton RC; Zhang Z
Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):351-357. PubMed ID: 28538015
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin receptor in immune-mediated renal tubular injury in trichloroethylene-sensitized mice: Impact on NF-κB signaling pathway.
Yang L; Zhang J; Li N; Xie H; Chen S; Wang H; Shen T; Zhu QX
J Immunotoxicol; 2018 Dec; 15(1):126-136. PubMed ID: 30409067
[TBL] [Abstract][Full Text] [Related]
16. The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney.
Phipps JA; Feener EP
Kidney Int; 2008 May; 73(10):1114-9. PubMed ID: 18272958
[TBL] [Abstract][Full Text] [Related]
17. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.
Desposito D; Chollet C; Taveau C; Descamps V; Alhenc-Gelas F; Roussel R; Bouby N; Waeckel L
Clin Sci (Lond); 2016 Jan; 130(1):45-56. PubMed ID: 26443866
[TBL] [Abstract][Full Text] [Related]
18. Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin.
Mamenko M; Zaika O; Doris PA; Pochynyuk O
Hypertension; 2012 Nov; 60(5):1234-41. PubMed ID: 23033373
[TBL] [Abstract][Full Text] [Related]
19. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.
Marceau F; Larrivée JF; Bouthillier J; Bachvarova M; Houle S; Bachvarov DR
Am J Physiol; 1999 Dec; 277(6):R1568-78. PubMed ID: 10600901
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms mediating the vasoactive effects of the B1 receptors of bradykinin.
Duka I; Duka A; Kintsurashvili E; Johns C; Gavras I; Gavras H
Hypertension; 2003 Nov; 42(5):1021-5. PubMed ID: 14557281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
